27.10.11
MHRA consultation launched
The Medicines and Healthcare products Regulatory Agency (MHRA) has launched a formal public consultation on the consolidation of UK medicines legislation, to simplify and clarify the law for regulating medicine.
Draft regulations will be tested to ensure they are accurate, user-friendly and do not introduce any unintended changes. This forms part of the MHRA’s Regulatory Excellence programme, which aims to keep legislation fit for purpose and reflecting modern practice.
MHRA chief executive, Sir Kent Woods, said: “Medicines legislation which has been amended many times over several decades can be greatly simplified by consolidation. The current need for this has received widespread support from both pharmacists and the pharmaceutical industry.
“It will amalgamate 40 years’ of outdated and fragmented legislation, reducing it by around two thirds, making it clearer and easier to understand as well as ensuring that medicines regulation is supported by a modern and straightforward legal framework.”
The Association of British Pharmaceutical Industry (ABPI) chief executive, Stephen Whitehead, said: “The ABPI welcomes this opportunity to contribute to providing clearer legislation and encourages our members to actively participate in the consultation.”
The Proprietary Association of Great Britain director of legal and regulatory affairs, Helen Darracott, also commented: “The work to consolidate the complex UK medicines legislation is very much welcomed by the over-the-counter medicines industry.
“We look forward to engaging in the consultation to deliver a more concise and simplified legal text that is clear, meaningful and user-friendly to work with.”
The finalised consolidated legislation is due to come into force in July 2012. You can contribute to the consultation at www.mhra.gov.uk
Tell us what you think – have your say below, or email us directly at [email protected]